SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen PreparednessKizzmekia S. Corbett, Tracy J. Ruckwardt, Cynthia T. Ziwawo et al.|bioRxiv (Cold Spring Harbor Laboratory)|2020Cited by 143
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein induces genetically and antigenically diverse antibody responsesMaryam Mukhamedova, John R. Mascola, Daniel Wrapp et al.|Immunity|2021Cited by 71
Vaccination with prefusion-stabilized respiratory syncytial virus fusion protein elicits antibodies targeting a membrane-proximal epitopeRyan S. McCool, Jason S. McLellan, Maryam Musayev et al.|Journal of Virology|2023Cited by 19
Molecular Dissection Of Human Antibody Responses Following Prefusion-Stabilized RSV F VaccinationMaryam Mukhamedova, John R. Mascola, Daniel Wrapp et al.|SSRN Electronic Journal|2020Cited by 0